chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tenderness
Clinical narrative: tested positive; tested positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to obtain information for receiving the second dose if she tested positive after receiving the first dose. She received the first dose on 21Dec2020, was exposed on 26Dec2020, tested positive on 02Jan2021 and went to the ER but was now feeling better. She wanted to know if she can still get the second vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: tested positive; tested positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to obtain information for receiving the second dose if she tested positive after receiving the first dose. She received the first dose on 21Dec2020, was exposed on 26Dec2020, tested positive on 02Jan2021 and went to the ER but was now feeling better. She wanted to know if she can still get the second vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, COVID-19, Chest X-ray, Exposure to SARS-CoV-2, Influenza virus test negative
Clinical narrative: tested positive; tested positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to obtain information for receiving the second dose if she tested positive after receiving the first dose. She received the first dose on 21Dec2020, was exposed on 26Dec2020, tested positive on 02Jan2021 and went to the ER but was now feeling better. She wanted to know if she can still get the second vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Lymph node pain, Lymphadenopathy, Pain, Pneumonia
Clinical narrative: tested positive; tested positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to obtain information for receiving the second dose if she tested positive after receiving the first dose. She received the first dose on 21Dec2020, was exposed on 26Dec2020, tested positive on 02Jan2021 and went to the ER but was now feeling better. She wanted to know if she can still get the second vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: tested positive; tested positive; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to obtain information for receiving the second dose if she tested positive after receiving the first dose. She received the first dose on 21Dec2020, was exposed on 26Dec2020, tested positive on 02Jan2021 and went to the ER but was now feeling better. She wanted to know if she can still get the second vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Breast tenderness, Chest pain, Cough, Dyspnoea
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, Headache, Influenza virus test negative, Injection site pain, Lymph node pain
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Pain, Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tenderness
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, COVID-19, Chest X-ray, Exposure to SARS-CoV-2, Influenza virus test negative
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Lymph node pain, Lymphadenopathy, Pain, Pneumonia
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: diagnosed with Covid-19 after the 1st dose; diagnosed with Covid-19 after the 1st dose; Pneumonia; Fever; Body aches; swollen lymph nodes under left armpit; Exposed to COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a 51-year-old female patient received the first does of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 08:30 in left arm at single dose for covid-19 immunization. The patient medical history was none. Family medical history was no. Patient had been taking vitamin supplements. No vaccinations were taken within 4 weeks. Patient received first COVID-19 Vaccine on 21Dec2020 around 08:30. Between that three weeks period, patient was diagnosed with COVID. Patient was exposed the following weekend. Took four tests to finally test positive within a four-day-span. Patient was exposed to COVID on 26Dec2020. On 28Dec2020, patient experienced swollen lymph nodes under left armpit. Progressively got more sensitive on 29Dec2020.  Patient thought maybe it was a side effect of the COVID-19 Vaccine. Wednesday morning, 30Dec2020, around 10:00 patient noticed body aches. Around 12:00 patient noticed a fever. On 30Dec2020, patient had a 24-hour lab test to check for COVID. All other COVID tests performed were rapid tests. First COVID test was on 30Dec2020. Patient had another COVID test on 31Dec2020, and two COVID tests on 02Jan2021. Patient was tested positive for COVID on 02Jan2021. COVID test that resulted positive was a rapid test in the emergency room. Patient was diagnosed with Covid-19 after the 1st dose. Patient was in the emergency room with pneumonia which occurred on 02Jan2021. It was confirmed patient was discharged from the emergency room six to seven hours after arrival. Lot number from patient card was either EJ1685 or ET1685. Caller unable to confirm lot number from patient card. Chest X-ray was what sent her to emergency room labs and blood work done on 02Jan2021 in emergency room. Labs were done in clinic a couple days before flu and strep test both negative on an unspecified date. Patient didn't remember all tests and results.  Outcome of all events were unknown. Caller would like to know whether she should take the 2nd dose or not.  Information on the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: About 15 min I felt numbness and tingling on my face. Gradually  felt it in my whole body by 8:30PM that night, next day I tried to go to work but I had to leave because of the intense numbness and tingling. I also developed left leg weakness and had to even pick up my leg to be able to walk. The NP at my neurologist office (talked over the phone) said it was a pseudo effect due to my MS. My symptoms are still intermittent up to my second dose.  It is all over the numbness and tingling, but as it is subsiding it is now flaring up my symptoms from 2 years ago and I feel it on my second side.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Impaired work ability, Muscular weakness, Paraesthesia
Clinical narrative: About 15 min I felt numbness and tingling on my face. Gradually  felt it in my whole body by 8:30PM that night, next day I tried to go to work but I had to leave because of the intense numbness and tingling. I also developed left leg weakness and had to even pick up my leg to be able to walk. The NP at my neurologist office (talked over the phone) said it was a pseudo effect due to my MS. My symptoms are still intermittent up to my second dose.  It is all over the numbness and tingling, but as it is subsiding it is now flaring up my symptoms from 2 years ago and I feel it on my second side.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Paraesthesia, Pruritus, Rash
Clinical narrative: Starting itching, then face and lips started tingling. Took Benadryl and Pepcid. Next morning started having difficultly swallowing, went to ER-1-6-21 On 1-7-21 started itching from all over, blood pressure was 262/106, went back to ER
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Paraesthesia, Paraesthesia oral, Pruritus
Clinical narrative: Starting itching, then face and lips started tingling. Took Benadryl and Pepcid. Next morning started having difficultly swallowing, went to ER-1-6-21 On 1-7-21 started itching from all over, blood pressure was 262/106, went back to ER
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood pressure increased, Chest discomfort, Chills, Electrocardiogram
Clinical narrative: Patient stated had tingling in hands/feet; headache; observed for 30 minutes then began to c/o chest tightness; swelling on left side of face. 50mg IM diphenhydramine administered per MD; 911 intiated; patient refused transport; sent to triage area - released from triage same day.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Paraesthesia, Pyrexia, Swelling face
Clinical narrative: Patient stated had tingling in hands/feet; headache; observed for 30 minutes then began to c/o chest tightness; swelling on left side of face. 50mg IM diphenhydramine administered per MD; 911 intiated; patient refused transport; sent to triage area - released from triage same day.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Headache, Paraesthesia, Swelling face
Clinical narrative: Patient stated had tingling in hands/feet; headache; observed for 30 minutes then began to c/o chest tightness; swelling on left side of face. 50mg IM diphenhydramine administered per MD; 911 intiated; patient refused transport; sent to triage area - released from triage same day.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Erythema, Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: Left calf pain and swelling, +DVT
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: Left calf pain and swelling, +DVT
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Pain in extremity, Peripheral swelling
Clinical narrative: Left calf pain and swelling, +DVT
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lacrimation increased, Throat irritation
Clinical narrative: Itchy throat and watery eyes.  Benadryl administered with initial resolution of symptoms.  Later, patient experienced swelling of eyes, cheeks and mouth.  Advised to take Benadryl q6h.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Pregnancy, Swelling face, Throat irritation
Clinical narrative: Itchy throat and watery eyes.  Benadryl administered with initial resolution of symptoms.  Later, patient experienced swelling of eyes, cheeks and mouth.  Advised to take Benadryl q6h.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eye swelling, Lacrimation increased, Mouth swelling, Swelling face, Throat irritation
Clinical narrative: Itchy throat and watery eyes.  Benadryl administered with initial resolution of symptoms.  Later, patient experienced swelling of eyes, cheeks and mouth.  Advised to take Benadryl q6h.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Vaccine site was sore and slightly swollen for a week after receiving vaccine. On 01/06/21, the vaccine site became red about 3 inches in diameter with a defined border. It also became more swollen and itchy. This lasted for 5 days and then started shrinking. On 01/15/21 hives started. Every evening since 01/15/21, there has been an extreme case of hives on the knees, arms, and back. As of 01/26/21, the hives are still ongoing. Patient has been self-treating with Benadryl.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus, Urticaria, Vaccination site pain, Vaccination site swelling
Clinical narrative: Vaccine site was sore and slightly swollen for a week after receiving vaccine. On 01/06/21, the vaccine site became red about 3 inches in diameter with a defined border. It also became more swollen and itchy. This lasted for 5 days and then started shrinking. On 01/15/21 hives started. Every evening since 01/15/21, there has been an extreme case of hives on the knees, arms, and back. As of 01/26/21, the hives are still ongoing. Patient has been self-treating with Benadryl.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: fatgiue; chills; low grade fever; pain around injection area; short time of nausea; headache; muscle pain and joint pain; muscle pain and joint pain; This is spontaneous report from a contactable consumer. This (age: 31; units: unknown) female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on an unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient reported AE to the first dose of the covid 19 vaccine (she got the vaccine about 2 weeks ago): fatigue, chills, low grade fever, pain around injection area, short time of nausea, headache, muscle pain and joint pain. It did improve after she took paracetamol (TYLENOL) and after 24 hours, it was improved, but she was still wondering should she get 2nd dose on time or delay it. Outcome of events was recovering.  Information on lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: fatgiue; chills; low grade fever; pain around injection area; short time of nausea; headache; muscle pain and joint pain; muscle pain and joint pain; This is spontaneous report from a contactable consumer. This (age: 31; units: unknown) female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on an unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient reported AE to the first dose of the covid 19 vaccine (she got the vaccine about 2 weeks ago): fatigue, chills, low grade fever, pain around injection area, short time of nausea, headache, muscle pain and joint pain. It did improve after she took paracetamol (TYLENOL) and after 24 hours, it was improved, but she was still wondering should she get 2nd dose on time or delay it. Outcome of events was recovering.  Information on lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain
Clinical narrative: fatgiue; chills; low grade fever; pain around injection area; short time of nausea; headache; muscle pain and joint pain; muscle pain and joint pain; This is spontaneous report from a contactable consumer. This (age: 31; units: unknown) female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on an unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient reported AE to the first dose of the covid 19 vaccine (she got the vaccine about 2 weeks ago): fatigue, chills, low grade fever, pain around injection area, short time of nausea, headache, muscle pain and joint pain. It did improve after she took paracetamol (TYLENOL) and after 24 hours, it was improved, but she was still wondering should she get 2nd dose on time or delay it. Outcome of events was recovering.  Information on lot/batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Lip swelling, Oropharyngeal pain, Palpitations, Speech disorder
Clinical narrative: AROUND 15 MINS AFTER VACCINE MY HEART FELT FLUTTERY, THEY CHECKED MY VITALS EVERYTHING WAS OKAY 5 MINS AFTER MY THROAT STARTED CLOSING AND I WAS FEELING FAINT. MY LIPS SWELLED. I RECEIVED EPI, STEROIDS AND BENADRYL THROUGH AN IV. STAYED ON OXYGEN OVERNIGHT. DISCHARGED AFTER A DAY. TOOK PREDNISONE, PEPCID AND BENADRYL AT HOME.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: AROUND 15 MINS AFTER VACCINE MY HEART FELT FLUTTERY, THEY CHECKED MY VITALS EVERYTHING WAS OKAY 5 MINS AFTER MY THROAT STARTED CLOSING AND I WAS FEELING FAINT. MY LIPS SWELLED. I RECEIVED EPI, STEROIDS AND BENADRYL THROUGH AN IV. STAYED ON OXYGEN OVERNIGHT. DISCHARGED AFTER A DAY. TOOK PREDNISONE, PEPCID AND BENADRYL AT HOME.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac flutter, Dizziness, Lip swelling, Throat tightness
Clinical narrative: AROUND 15 MINS AFTER VACCINE MY HEART FELT FLUTTERY, THEY CHECKED MY VITALS EVERYTHING WAS OKAY 5 MINS AFTER MY THROAT STARTED CLOSING AND I WAS FEELING FAINT. MY LIPS SWELLED. I RECEIVED EPI, STEROIDS AND BENADRYL THROUGH AN IV. STAYED ON OXYGEN OVERNIGHT. DISCHARGED AFTER A DAY. TOOK PREDNISONE, PEPCID AND BENADRYL AT HOME.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Thumb itching, tongue and throat swelling--transferred to Urgent Care.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pharyngeal swelling, Pruritus, Swollen tongue
Clinical narrative: Thumb itching, tongue and throat swelling--transferred to Urgent Care.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Acute kidney injury, Anaphylactic reaction, Dyspnoea, Pain
Clinical narrative: Thumb itching, tongue and throat swelling--transferred to Urgent Care.
Age: 59.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasm and get hurt from head to toe; major muscle spasm; think if my husband touch me I would kill him; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 09Jan2021 at a single dose for COVID-19 immunization. Medical history included Crohn's disease ("it's auto immune disorder in the digestive system"). The patient's concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization and was a little sore. On Saturday the patient got her second Pfizer vaccine (Covid Vaccine) and stated, "I feel like I am in  a "giant" "terrible" (not clarified) because one time muscle spasm from head to toe. I think if my husband touch me I would kill him and I am taking a single. Just a major muscle spasm and I wanted to know, what should I tell my doctor to give me? Should I tell him to give me pain medication, muscle relaxers (Unspecified Medication)? Is it going to affect the effectiveness of the shot?" The patient took ibuprofen to try ease it out that didn't work. The outcome of the event was not recovered. Vaccination type facility was hospital.  Information about Lot/Batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulse abnormal, Swelling, Ultrasound scan
Clinical narrative: neck was mildly swollen/mild superficial neck swelling; bounding pulse (palpitations); bounding pulse (palpitations); This is a spontaneous report from a contactable consumer on behalf of herself.  A 48-year-old female patient received her first BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EH9899, via an unspecified route of administration on 28Dec2020 at SINGLE DOSE at left upper arm for COVID-19 immunisation.  There were no relevant medical histories or concomitant medications.  The patient had a vaccination on 28Dec2020 and seven days later on 04Jan2021 her neck was mildly swollen and that same day it became more swollen and she had a bounding pulse also reported that had mild superficial neck swelling and a bounding pulse in her neck. The swelling has gone down, but got worse in the evening. The bounding pulse (palpitations) in her neck has improved but got worst at night, still occurred at night. No difficulty breathing and/or swallowing. She went to her physician on 05Jan2021 to find out why occurring. She was called to see if based off this symptom if she should have her second shot of vaccination. Followed up with her MD and had an Ultrasound (US) of her jugular in Jan2021 and all was normal. The outcome of the events was resolving.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Palpitations, Pulse abnormal, Swelling, Ultrasound scan
Clinical narrative: neck was mildly swollen/mild superficial neck swelling; bounding pulse (palpitations); bounding pulse (palpitations); This is a spontaneous report from a contactable consumer on behalf of herself.  A 48-year-old female patient received her first BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EH9899, via an unspecified route of administration on 28Dec2020 at SINGLE DOSE at left upper arm for COVID-19 immunisation.  There were no relevant medical histories or concomitant medications.  The patient had a vaccination on 28Dec2020 and seven days later on 04Jan2021 her neck was mildly swollen and that same day it became more swollen and she had a bounding pulse also reported that had mild superficial neck swelling and a bounding pulse in her neck. The swelling has gone down, but got worse in the evening. The bounding pulse (palpitations) in her neck has improved but got worst at night, still occurred at night. No difficulty breathing and/or swallowing. She went to her physician on 05Jan2021 to find out why occurring. She was called to see if based off this symptom if she should have her second shot of vaccination. Followed up with her MD and had an Ultrasound (US) of her jugular in Jan2021 and all was normal. The outcome of the events was resolving.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Influenza like illness
Clinical narrative: Flu like symptoms, fatigue, chills; Flu like symptoms, fatigue, chills; Flu like symptoms, fatigue, chills; This is a spontaneous report from a contactable pharmacist (patient).  A 43-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK9231, expiration date not reported), via an unspecified route of administration on 11Jan2021 13:00 at a single dose for Covid-19 immunization.  Medical history included sulfa allergies.  Concomitant medications included ergocalciferol (VIT D) and docusate sodium (COLACE).  The patient previously took first dose of bnt162b2 (Lot number: EK5730, lot unknown: False, administration date:21Dec2020 :01:00 PM,vaccine location: Right arm, dose number:1), azithromycin and experienced allergies. On 11Jan2021 at 23:30, the patient experienced flu like symptoms, fatigue, chills. Outcome of the events was not recovered
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Joint pain; Arm swelled up from the shoulder to the elbow and around to the inner arm; It is hot, hard, swollen, and extremely painful; from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful.; Arm swelled up from the shoulder to the elbow and around to the inner arm; Headache; Low grade fever of 100.2F; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176; expiry date: unknown) via an unspecified route of administration in the left arm on 08Jan2021 on 15:00, at a single dose, for COVID-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), bariatric surgery, seasonal allergies, and known allergies to bee stings, flu vaccine, and monosodium glutamate (MSG). Concomitant medications included famotidine (PEPCID) and cetirizine hydrochloride (ZYRTEC), and multivitamins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) on 17Dec2020, at 01:00 PM, in the left arm, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital.  On 09Jan2021, at 14: 30, the patient's arm swelled up from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful. She also had joint pain, headache, and low-grade fever of 100.2 Fahrenheit (F). The patient did not received therapy for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site warmth, Pyrexia
Clinical narrative: Joint pain; Arm swelled up from the shoulder to the elbow and around to the inner arm; It is hot, hard, swollen, and extremely painful; from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful.; Arm swelled up from the shoulder to the elbow and around to the inner arm; Headache; Low grade fever of 100.2F; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176; expiry date: unknown) via an unspecified route of administration in the left arm on 08Jan2021 on 15:00, at a single dose, for COVID-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), bariatric surgery, seasonal allergies, and known allergies to bee stings, flu vaccine, and monosodium glutamate (MSG). Concomitant medications included famotidine (PEPCID) and cetirizine hydrochloride (ZYRTEC), and multivitamins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) on 17Dec2020, at 01:00 PM, in the left arm, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital.  On 09Jan2021, at 14: 30, the patient's arm swelled up from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful. She also had joint pain, headache, and low-grade fever of 100.2 Fahrenheit (F). The patient did not received therapy for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Feeling hot, Headache, Joint swelling
Clinical narrative: Joint pain; Arm swelled up from the shoulder to the elbow and around to the inner arm; It is hot, hard, swollen, and extremely painful; from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful.; Arm swelled up from the shoulder to the elbow and around to the inner arm; Headache; Low grade fever of 100.2F; This is a spontaneous report from a contactable other healthcare professional. A 43-year-old female patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176; expiry date: unknown) via an unspecified route of administration in the left arm on 08Jan2021 on 15:00, at a single dose, for COVID-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), bariatric surgery, seasonal allergies, and known allergies to bee stings, flu vaccine, and monosodium glutamate (MSG). Concomitant medications included famotidine (PEPCID) and cetirizine hydrochloride (ZYRTEC), and multivitamins. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) on 17Dec2020, at 01:00 PM, in the left arm, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital.  On 09Jan2021, at 14: 30, the patient's arm swelled up from the shoulder to the elbow and around to the inner arm. It was hot, hard, swollen, and extremely painful. She also had joint pain, headache, and low-grade fever of 100.2 Fahrenheit (F). The patient did not received therapy for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.